首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >The Protective Effects of Cobra Venom from Naja naja atra on Acute and Chronic Nephropathy
【2h】

The Protective Effects of Cobra Venom from Naja naja atra on Acute and Chronic Nephropathy

机译:眼镜蛇毒对急性和慢性肾病的保护作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study investigated the effects of Naja naja atra venom (NNAV) on acute and chronic nephropathy in rats. Rats received 6 mg/kg adriamycin (ADR) once to evoke the chronic nephropathy or 8 ml/kg 50% v/v glycerol to produce acute renal failure (ARF). The NNAV was given orally once a day starting five days prior to ADR or glycerol injection and continued to the end of experiments. The animals were placed in metabolic cages for 24 h for urine collection for urinary protein determination. The kidney function-related biochemical changes and index of oxidative stress were determined with automatic biochemistry analyzer or colorimetric enzyme assay kits. The pathomorphological changes were observed using light and transmission electron microcopies. The levels of inflammatory cytokines and NF-κB activation were determined using ELISA kits, Western blot analysis, or immunofluorescence. The results showed that NNAV relieved ADR-induced chronic nephropathy and glycerol-triggered acute renal failure syndromes including proteinuria, hypoalbuminemia, hyperlipidemia, serum electrolyte unbalance, renal oxidative stress, and pathological damages. NNAV reduced kidney levels of TNF-α and IL-1β, but it increased the levels of IκB-α and inhibited NF-κB p65 nuclear localization. These findings suggest that NNAV may be a valuable therapeutic drug for acute and chronic kidney diseases.
机译:这项研究调查了眼镜蛇眼镜蛇毒(NNAV)对大鼠急性和慢性肾病的影响。大鼠一次会诱发6毫克/千克阿霉素(ADR)引起慢性肾病,或8毫升/千克50%v / v甘油引起急性肾衰竭(ARF)。从ADR或甘油注射前五天开始,每天一次口服NNAV,并一直持续到实验结束。将动物放置在代谢笼中24小时,以收集尿液以确定尿蛋白。用自动生化分析仪或比色酶测定试剂盒测定肾脏功能相关的生化变化和氧化应激指数。使用光和透射电子显微镜观察病理形态学变化。使用ELISA试剂盒,Western印迹分析或免疫荧光测定炎症细胞因子和NF-κB活化水平。结果显示,NNAV可缓解ADR引起的慢性肾病和甘油触发的急性肾衰竭综合征,包括蛋白尿,低白蛋白血症,高脂血症,血清电解质失衡,肾脏氧化应激和病理损害。 NNAV降低肾脏的TNF-α和IL-1β水平,但增加IκB-α水平并抑制NF-κBp65核定位。这些发现表明,NNAV可能是用于急慢性肾脏疾病的有价值的治疗药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号